2/24/2023 0 Comments Robert gish![]() ![]() ![]() In addition, he is also Medical Director of the Hepatitis B Foundation in Doylestown, Pennsylvania. ![]() He serves as an Adjunct Professor of Pharmacy at Skaggs School of Pharmacy and Pharmaceutical Sciences at UCSD, a Professor of Medicine at Loma Linda University as well as a Staff Physician Loma Linda University’s Liver Transplant Clinic in Las Vegas. Gish, MD, is currently an Adjunct Professor of Medicine at the University of Nevada Schools of Medicine in Las Vegas and in Reno. He has published more than 700 original articles, review articles, abstracts, and book chapters. Specialties: Gastroenterology (Board Certified) Hepatology (Board Certified). Gish completed a residency at University of California, San Diego. He was involved in studies that led to the genotypic classification strategies and methods now in use worldwide. Robert Gish, MD is a gastroenterology specialist in La Jolla, CA. He was a major early contributor to decipherment methods for the detection of hepatitis B and C virus and characterizing its epidemiology and clinical presentation in humans. He has co-authored a public health policy for liver health in Vietnam focusing on HBV and is also assisting with the development of viral hepatitis health care policies in Georgia, Armenia, and the Philippines. He has served on the editorial boards of American Journal of Gastroenterology, Hepatology, Journal of Hepatology, Digestive Diseases and Sciences, and Gastroenterology, among many others. Gish is a fellow of the American Association for the Study of Liver Disease, the American Society of Transplantation and the American College of Physicians. He completed a 3-year internal medicine residency at the University of California, San Diego, and a 4-year gastroenterology and hepatology fellowship at the University of California, Los Angeles which included transplant medicine.ĭr. Dr Gish was first in Pharmacy School at the University of Kansas and then obtained his medical degree from the University of Kansas Medical School in Kansas City, Kansas. Gish was the principle investigator in a study that was started in 2012 to investigate the effects of PSI-352938, PSE-7977 and Ribavirin in patients with Chronic HCV. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |